LENACAPAVIR
Clinical trials for LENACAPAVIR explained in plain language.
Never miss a new study
Get alerted when new LENACAPAVIR trials appear
Sign up with your email to follow new studies for LENACAPAVIR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Long-Acting HIV shots aim to keep virus in check
Disease control Not yet recruitingThis study looks at how well a long-acting HIV treatment works. It combines two drugs, cabotegravir and lenacapavir, given as shots. The goal is to see if the treatment keeps the virus under control and is safe. About 50 adults with HIV who are already on or starting this combo w…
Matched conditions: LENACAPAVIR
Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba • Aim: Disease control
Last updated May 17, 2026 05:29 UTC
-
Shielding south african youth from HIV prevention myths
Knowledge-focused Not yet recruitingThis study tests whether a brief 'psychological inoculation' message can help young women in South Africa resist false claims about lenacapavir, a new twice-yearly injection that prevents HIV. About 1,500 women aged 18-29 will be randomly assigned to receive either the inoculatio…
Matched conditions: LENACAPAVIR
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 17, 2026 05:30 UTC